Validation of a new intraarterial microdialysis shunt probe for the estimation of pharmacokinetic parameters

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 6, 2003, Pages 1109-1117

  Höcht, Christian ^a   Opezzo, Javier A W ^a   Taira, Carlos A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Blood sampling; Intraarterial microdialysis shunt probe; Irbesartan; Pharmacokinetics; Protein binding

Indexed keywords

IRBESARTAN;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL SHUNT; CANNULATION; CAROTID ARTERY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; FEMORAL VEIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MECHANICAL PROBE; MICRODIALYSIS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT; VALIDATION PROCESS;

EID: 0037430782     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00652-0     Document Type: Article

References (22)

1. Ungerstedt U. Mardsden C.A. Measurement of Neurotransmitter Release in vivo. 1984;81-105 Wiley, London.
2. Brodie M.S., Lee K., Fredholm B.B., Ståhle L., Dunwiddie T.V. Brain Res. 415:1987;323-330.
3. Ben-hun J., Cooper R.L., Cringle S.J., Constable I.J. Arch. Ophthalmol. 106:1988;254-259.
4. Hurd Y.L., Kehr J., Ungerstedt U. J. Neurochem. 51:1988;1314-1316.
5. Chen Z., Steger R.W. J. Pharmacol. Toxicol. Methods. 29:1993;111-118.
6. Elmquist W.F., Sawchuk R.J. Pharm. Res. 14:1997;267-288.
7. Scott D.O., Sorensen L.R., Lunte C.E. J. Chromatogr. 506:1990;461-469.
8. Lonnroth P., Carlsten J., Johnson L., Smith U. J. Chromatogr. 568:1991;419-425.
9. Alonso M.J., Bruelisauer A., Misslin P., Lemaire M. Pharm. Res. 12:1995;291-294.
10. Quellec A.L., Dupin S., Tufenkj A.E., Genissel P., Houin G. Pharm. Res. 11:1994;835-838.
11. Evrard P.A., Cumps J., Verbeeck R.K. Pharm. Res. 13:1996;18-22.
12. González L., López J.A., Alonso R.M., Jiménez R.M. J. Chromatogr. A. 949:2002;49-60.
13. Ståhle L. Eur. J. Clin. Pharmacol. 43:1992;289-294.
14. Opezzo J.A.W., Höcht C., Taira C.A., Bramuglia G.F. Pharmacol. Res. 43:2001;155-159.
15. Opezzo J.A.W., Höcht C., Taira C.A., Bramuglia G.F. Pharmacol. Res. 41:2000;455-459.
16. Höcht C., Opezzo J.A.W., Gorzalczany S.B., Priano R.M., Bramuglia G.F., Taira C.A. Pharmacol. Res. 44:2001;377-383.
17. Ungerstedt U. J. Int. Med. 230:1991;365-373.
18. Benveniste H., Huttemeier P.C. Prog. Neurobiol. 33:1990;195-215.
19. Yang H., Wang Q., Elmquist W.F. Pharm. Res. 13:1996;1570-1575.
20. Wang Y., Wong S.L., Sawchuk R.J. Pharm. Res. 10:1993;1411-1419.
21. Yokel R.A., Allen D.D., Burgio D.E., McNamara P.J. J. Pharmacol. Methods. 25:1992;135-142.
22. Davi H., Tronquet C., Miscoria G., Perrier L., DuPont P., Caix J., Simiand J., Berger Y. Drug. Metab. Dispos. 28:2000;79-88.